U.S. Market for Interventional Cardiology Devices

A complete overview of every segment within this report. This summary includes an abridged competitive analysis, partial numerical data, CAGRS, and qualitative synopses. In 2012, the U.S. interventional cardiology devices market was valued at over $3.5 billion, a 1.6% increase over 2011.

Advancements in specific technologies and practices such as drug management, drug-eluting stents, specialty guidewires, micro-introducer sheaths, fractional flow reserve guidewires and various imaging modalities will account for a great deal of the growth in the total market for interventional cardiology devices in the United States. Many of the established standard items have become commodities and are close to homogeneous in their substitutability. Thus it has been and will continue to be the role of new or specialized devices that receive positive clinical trials to act as catalysts for growth and to increase the market share of companies that are able to capitalize on the opportunity. For established items such as angioplasty accessory kits, companies will be able to utilize distribution networks as well as the competitive advantage that is provided by the bundling of multiple items.

Scope:

This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.

Report Contents:

• Competitor Analysis
• Identified Strategic Opportunities
• Market Overview by Segment
• Trend Analysis by Segment
• Market Drivers & Limiters
• Mergers & Acquisitions
• Customer Feedback and Market Monitoring

Main Segments Included:

• Drug-eluting stents
• Bare-metal stents
• Percutaneous transluminal coronary angioplasty (PTCA)
• Cutting balloons catheters
• Balloon-inflation devices
• Angioplasty accessory kits
• Interventional catheters and guidewires
• Diagnostic catheters and guidewires
• Coronary introducer sheaths
• Embolic protection devices
• Atherectomy devices
• Thrombectomy devices
• Chronic total occlusion (CTO) devices
• Vascular closure devices (VCDs)
• Intravascular ultrasound (IVUS) catheters
• Potential markets for vulnerable plaque screening

Companies Included:

• AngioDynamics
• Spectranetics
• Argon Medical
• Volcano Therapeutics
• AccessClosure
• Merit Medical Systems
• B. Braun
• C. R. Bard
• Marine Polymer Technologies
• Smiths Medical
• Teleflex Medical
• AngioScore FlowCardia
• Asahi Medical
• BostonScientific
• Abbott Laboratories
• St.Jude Medical
• Medtronic
• Cordis
• Cook Medical
• Vascular Solutions
• MedRAD Interventional/Possis
• Terumo
• Covidien
• Galt Medical

Table Of Contents

Table Of Contents I
List Of Figures IX
List Of Charts  XV

Executive Summary 1
1.1 Interventional Cardiology Device Market 1
1.2 Bare-Metal And Drug-Eluting Stent Market 3
1.3 Ptca And Cutting Balloon Market 4
1.4 Balloon-Inflation Devices & Angioplasty Kit Market 5
1.5 Interventional Coronary Catheter & Guidewire Markets 6
1.6 Coronary Embolic Protection Device Market 7
1.7 Coronary Atherectomy Device Market 7
1.8 Coronary Thrombectomy Device Market 8
1.9 Coronary Chronic Total Occlusion Crosser Market 9
1.10 Introducer Sheath Market 10
1.11 Coronary Vascular Closure Device Market 11
1.12 Diagnostic Coronary Catheter And Guidewire Market 12
1.13 Ivus Catheter Market 13
1.14 Optical Coherence Tomography (Oct) Device Market 13
1.15 Vulnerable Plaque Device Market 14
1.16 Competitive Analysis 15

Research Methodology 16
2.1 Research Scope 16
2.2 Idata’s 9-Step Methodology 16
Step 1: Project Initiation & Team Selection 17
Step 2: Prepare Data Systems And Perform Secondary Research 19
Step 3: Preparation For Interviews & Questionnaire Design 20
Step 4: Performing Primary Research 21
Step 5: Research Analysis: Establishing Baseline Estimates 23
Step 6: Market Forecast And Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review And Market Release 24
Step 9: Customer Feedback And Market Monitoring 24

U.S. Interventional Cardiology Device Market 25
3.1 Introduction 25
3.1.1 Population At Risk 25
3.2 Procedures 28
3.2.1 Angioplasty And Angiography Procedures 28
3.2.2 Angiography Procedures 28
3.2.3 Angioplasty Procedures 29
3.3 Market Overview 31
3.4 Trend Analysis 37
3.5 Market Drivers And Limiters 40
3.5.1 Market Drivers 40
3.5.2 Market Limiters 40
3.6 Competitive Analysis 42
3.7 Mergers And Acquisitions 48

Bare-Metal And Drug-Eluting Stent Market 49
4.1 Introduction 49
4.2 Market Overview 52
4.3 Market Analysis & Forecast 54
4.3.1 Bare-Metal Stent Market 56
4.3.2 Drug-Eluting Stent Market 58
4.3.3 Units Sold 61
4.3.4 Stent Market By Delivery Platform 64
4.3.5 Stent Market By Stent Diameter 66
4.3.5.1 Bioabsorbable Stents 68
4.3.5.2 Bifurcated Stents 70
4.4 Drivers And Limiters 71
4.4.1 Market Drivers 71
4.4.2 Market Limiters 71
4.5 Competitive Analysis 73

PTCA And Cutting Balloon Catheter Market 77
5.1 Introduction 77
5.2market Overview 78
5.3 Market Analysis & Forecast 80
5.3.1 Total Balloon Catheter Market 80
5.3.2 Ptca Balloon Catheter Market 83
5.3.2.1 Unit Analysis 85
5.3.3 Cutting Balloon Catheter Market 87
5.3.3.1 Unit Analysis 89
5.4 Drivers And Limiters 91
5.4.1 Market Drivers 91
5.4.2 Market Limiters 92
5.5 Competitive Analysis 93

Balloon-Inflation Device Market 96
6.1 Introduction 96
6.2market Analysis & Forecast 97
6.3 Drivers And Limiters 99
6.3.1 Market Drivers 99
6.3.2 Market Limiters 99
6.4 Competitive Analysis 101

Angioplasty Accessory Kit Market 104
7.1 Introduction 104
7.2 Market Analysis & Forecast 105
7.3 Drivers And Limiters 107
7.3.1 Market Drivers 107
7.3.2 Market Limiters 107
7.4 Competitive Analysis 109

Interventional Coronary Catheter Market 112
8.1 Introduction 112
8.2 Market Overview 113
8.3 Market Analysis & Forecast 115
8.3.1 Unit Analysis 117
8.3.2 Interventional Guiding Catheter Market 119
8.3.3 Interventional Support Catheter Market 121
8.4 Drivers And Limiters 123
8.4.1 Market Drivers 123
8.4.2 Market Limiters 123
8.5 Competitive Analysis 125

Interventional Coronary Guidewire Market 128
9.1 Introduction 128
9.1.1 Device Construction 128
9.2 Market Overview 129
9.3 Market Analysis & Forecast 132
9.3.1 Unit Analysis 133
9.3.2 Conventional Guidewire Market 135
9.3.3 Specialized Guidewire Market 137
9.4 Drivers And Limiters 139
9.4.1 Market Drivers 139
9.4.2 Market Limiters 139
9.5 Competitive Analysis 141

Coronary Embolic Protection Device Market 144
10.1 Introduction 144
10.1.1 Saphenous Vein Grafts 144
10.1.2 Protection Mechanism 145
10.1.2.1 Filter Basket 145
10.1.2.2 Distal Balloon Occlusion 145
10.2 Market Analysis & Forecast 146
10.2.1 Penetration Rate 148
10.3 Drivers And Limiters 151
10.3.1 Market Drivers 151
10.3.2 Market Limiters 151
10.4 Competitive Analysis 153

Coronary Atherectomy Device Market 156
11.1 Introduction 156
11.1.1 Atherectomy 156
11.1.2 Device Technologies 157
11.1.2.1 Mechanical Atherectomy 157
11.1.2.2 Laser Atherectomy 157
11.1.2.3 Directional Coronary Atherectomy (Dca) 157
11.2 Market Overview 158
11.3 Market Analysis & Forecast 160
11.3.1 Penetration Rate 160
11.4 Drivers And Limiters 162
11.4.1 Market Drivers 162
11.4.2 Market Limiters 163
11.5 Competitive Analysis 164

Coronary Thrombectomy Device Market 167
12.1 Introduction 167
12.1.1 Drug-Eluting Stents And Thrombosis Treatment 167
12.2 Market Analysis & Forecast 168
12.2.1 Penetration Rate 170
12.3 Drivers And Limiters 172
12.3.1 Market Drivers 172
12.3.2 Market Limiters 172
12.4 Competitive Analysis 174

Coronary Chronic Total Occlusion Crosser Market 178
13.1 Introduction 178
13.2 Market Analysis & Forecast 179
13.2.1 Penetration Rate 182
13.2.2 Potential Market 184
13.3 Drivers And Limiters 186
13.3.1 Market Drivers 186
13.3.2 Market Limiters 187
13.4 Competitive Analysis 188

Introducer Sheath Market 191
14.1 Introduction 191
14.2 Market Overview 192
14.3 Market Analysis & Forecast 195
14.3.1 Standard Introducer Sheath Market 197
14.3.2 Micro-Introducer Sheath Market 199
14.4 Drivers And Limiters 201
14.4.1 Market Drivers 201
14.4.2 Market Limiters 201
14.5 Competitive Analysis 203

Coronary Vascular Closure Device Market 207
15.1 Introduction 207
15.1.1 Invasive And Non-Invasive Devices 207
15.2 Market Overview 208
15.3 Market Analysis & Forecast 210
15.3.1 Invasive Coronary Vascular Closure Device Market 212
15.3.2 Non-Invasive Coronary Vascular Closure Device Market 214
15.3.3 Penetration Rate 216
15.3.3.1 Diagnostic Procedures 216
15.3.3.2 Interventional Procedures 216
15.3.4 Coronary Vascular Closure Device Market By Access Site 219
15.3.4.1 Femoral Access Site 219
15.3.4.2 Radial Access Site 221
15.3.4.3 Brachial Access Site 223
15.4 Drivers And Limiters 225
15.4.1 Market Drivers 225
15.4.2 Market Limiters 225
Competitive Analysis 227

Diagnostic Coronary Catheter And Guidewire Market 231
16.1 Introduction 231
16.2 Market Overview 232
16.3 Market Analysis & Forecast 235
16.3.1 Diagnostic Coronary Catheter Market 237
16.3.1.1 Unit Analysis 239
16.3.1.2 Units Sold By Size 241
16.3.2 Diagnostic Coronary Guidewire Market 243
16.3.2.1 Unit Analysis 245
16.3.3 Fractional Flow Reserve (Ffr) Guidewire Market 247
16.3.3.1 Unit Analysis 249
16.4 Drivers And Limiters 251
16.4.1 Market Drivers 251
16.4.2 Market Limiters 251
16.5 Competitive Analysis 253

Intravascular Ultrasound Catheter Market 257
17.1 Introduction 257
17.1.1 Pre-Stenting Applications 257
17.1.2 Post-Stenting Applications 257
17.1.3 Ivus Console Penetration 258
17.2 Market Analysis & Forecast 259
17.2.1 Penetration Rate 261
17.3 Drivers And Limiters 263
17.3.1 Market Drivers 263
17.3.2 Market Limiters 264
17.4 Competitive Analysis 265

Optical Coherence Tomography (OCT) Device Market 268
18.1 Introduction 268
18.2 Market Overview 270
18.3 Market Analysis & Forecast 274
18.4 Drivers And Limiters 278
18.4.1 Market Drivers 278
18.4.2 Market Limiters 279
18.5 Competitive Analysis 280

Vulnerable Plaque Device Market 282
19.1 Introduction 282
19.1.1 Vulnerable Plaque Screening Technology 283
19.1.1.1 Intravascular Ultrasound (Ivus) 283
19.1.1.2 Optical Coherence Tomography (Oct) 283
19.1.1.3 Raman Spectroscopy 283
19.1.1.4 Near Infrared (Nir) Spectroscopy 284
19.1.1.5 Thermography 284
19.1.1.6 Intravascular Magnetic Resonance Imaging (Ivmri) 284
19.1.1.7 Computed Tomography (Ct) 284
19.1.2 Potential Vulnerable Plaque Treatments 285
19.1.2.1 Stents 285
19.1.2.2 Pharmaceuticals 285
19.1.2.3 Photodynamic Therapies 285
19.1.2.4 Cryotherapy 286
19.2 Target Population 287
19.3 Market Analysis And Forecast 289
19.3.1 Potential Vulnerable Plaque Screening Market 292
19.3.2 Potential Vulnerable Plaque Treatment Market 294
19.4 Drivers And Limiters 296
19.4.1 Market Drivers 296
19.4.2 Market Limiters 296
19.5 Competitive Analysis 297
19.5.1.1 Past Companies And Technology 299

Abbreviations 300